As life sciences organizations move beyond AI experimentation, the real challenge is not proving potential, it is scaling responsibly, sustainably, and measurably. This session presents a practical case study from Pfizer and Vivpro AI on how AI-enabled document generation is evolving into an enterprise-scale, governed production capability across R&D.
Rather than focusing on vision alone, this session will walk through the actual operating model used to scale: how cross-functional alignment was achieved, how quality and compliance expectations were embedded by design, and how change management enabled adoption across teams. Attendees will gain transparent insights into what worked well, what did not, and what the team would approach differently if starting again.
The speakers will share strategies for measuring value for R&D document generation with a focus on business impact.
Participants will leave with transferable patterns and practical guidance for moving from successful AI pilots to sustainable enterprise deployment of AI-enabled document generation for several document types across the medicinal product development lifecycle. This session is designed for leaders and practitioners seeking real-world lessons, implementation frameworks, and actionable insights they can apply within their own organizations.